Who owns Solve Therapeutics?

Solve Therapeutics is currently owned by Abingworth, through Abingworth Bioventures 8, since 2025.

When did Abingworth acquire Solve Therapeutics?

Abingworth acquired Solve Therapeutics in 2025 (active for 1 year).

Home/Companies/Biotech/Solve Therapeutics

Biotech·

US·Active·1yr hold

Solve Therapeutics is a healthcare company, headquartered in United States.

Entry

2025

Hold

1yr

Status

Active

Est. EV

–

Most recent investor

2 ownership periods

HQUnited States

SectorHealthcare

US biotechnology company developing antibody-drug conjugates for solid tumours; Abingworth participated in its 2025 Series C financing.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Already a member? Sign in

Other portfolio companies in the same fund.

Comparable biotech deals from other GPs.

Last updated April 2026 · Sourced from public filings